newsfilter
← Latest News
Business Wire·

Faeth Therapeutics Appoints Karen Vousden, Ph.D., to Board of Directors

Renowned cancer biologist and Faeth scientific co-founder joins the Board as the Company approaches topline Phase 2 data for PIKTOR in endometrial cancerFaeth Therapeutics, Inc. (NASDAQ:FTH), a clinical-stage